Terms: = Lung cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
709 results:
1. Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types.
Kim DK; Lee CY; Han YJ; Park SY; Han H; Na K; Kim MH; Yang SM; Baek S; Kim Y; Hwang JY; Lee S; Kang SS; Hong MH; Lim SM; Lee JB; Kim JH; Cho BC; Pyo KH
Front Immunol; 2024; 15():1330228. PubMed ID: 38680496
[TBL] [Abstract] [Full Text] [Related]
2. The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial.
Cheng B; Li C; Li J; Gong L; Liang P; Chen Y; Zhan S; Xiong S; Zhong R; Liang H; Feng Y; Wang R; Wang H; Zheng H; Liu J; Zhou C; Shao W; Qiu Y; Sun J; Xie Z; Liang Z; Yang C; Cai X; Su C; Wang W; He J; Liang W
Signal Transduct Target Ther; 2024 Apr; 9(1):93. PubMed ID: 38637495
[TBL] [Abstract] [Full Text] [Related]
3. High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
Han H; Huang H; Chen AP; Tang Y; Huang X; Chen C
PLoS One; 2024; 19(4):e0292726. PubMed ID: 38573879
[TBL] [Abstract] [Full Text] [Related]
4. Global, regional, and national burden of non-communicable diseases attributable to occupational asbestos exposure 1990-2019 and prediction to 2035: worsening or improving?
Miao X; Yao T; Dong C; Chen Z; Wei W; Shi Z; Xu T; Shao J; Niu Q; Rui D; Hu Y; Yan Y
BMC Public Health; 2024 Mar; 24(1):832. PubMed ID: 38500093
[TBL] [Abstract] [Full Text] [Related]
5. First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial.
Zhong H; Sun S; Chen J; Wang Z; Zhao Y; Zhang G; Chen G; Zhou M; Zhou J; Du Y; Wu L; Xu Z; Mei X; Zhang W; He J; Cui J; Zhang Z; Luo H; Liu W; Sun M; Wu J; Shen Y; Zhang S; Yang N; Wang M; Lu J; Li K; Yao W; Sun Q; Yue H; Wang L; Ye S; Li B; Zhuang X; Pan Y; Zhang M; Shu Y; He Z; Pan L; Ling Y; Liu S; Zhang Q; Jiao S; Han B
Lancet Respir Med; 2024 May; 12(5):355-365. PubMed ID: 38309287
[TBL] [Abstract] [Full Text] [Related]
6. Spread Through Air Spaces in Stage I to III Resected lung Adenocarcinomas: Should the Presence of Spread Through Air Spaces Lead to an Upstaging?
Laville D; Désage AL; Fournel P; Bayle-Bleuez S; Neifer C; Picot T; Sulaiman A; Tiffet O; Forest F
Am J Surg Pathol; 2024 May; 48(5):596-604. PubMed ID: 38298024
[TBL] [Abstract] [Full Text] [Related]
7. Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in cancer.
Prior O; Macarro C; Navarro V; Monreal C; Ligero M; Garcia-Ruiz A; Serna G; Simonetti S; Braña I; Vieito M; Escobar M; Capdevila J; Byrne AT; Dienstmann R; Toledo R; Nuciforo P; Garralda E; Grussu F; Bernatowicz K; Perez-Lopez R
Radiol Artif Intell; 2024 Mar; 6(2):e230118. PubMed ID: 38294307
[TBL] [Abstract] [Full Text] [Related]
8. Mortality of older construction and craft workers employed at Department of Energy (DOE) nuclear sites: Follow-up through 2021.
Ringen K; Dement J; Cloeren M; Almashat S; Hines S; Grier W; Quinn P; Chen A; Haas S
Am J Ind Med; 2024 Mar; 67(3):261-273. PubMed ID: 38273456
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
[TBL] [Abstract] [Full Text] [Related]
10. Significance of
Zou Z; Xu C; Li Z; Yang Y; Li Y; Sun Z; Li Q; Li M; Chen Y; Jiang G; Xiao M; Guo S; Wang Y; Wang H; Xia F; Shang Y; Wu J
Int J Med Sci; 2024; 21(3):474-482. PubMed ID: 38250608
[No Abstract] [Full Text] [Related]
11. [Comparison of efficacy and safety between domestic immune checkpoint inhibitors and pembrolizumab in the treatment of driver gene-negative advanced non-small cell lung cancer].
Chen YQ; Zhang YD; Yan H; Qin HY; Huang Z; Zhang X; Xiang SQ; Hu XQ; Wu F; Zhang YC; Zeng L; Yang N
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(4):282-289. PubMed ID: 38246773
[No Abstract] [Full Text] [Related]
12. Body composition radiomic features as a predictor of survival in patients with non-small cellular lung carcinoma: A multicenter retrospective study.
Rozynek M; Tabor Z; Kłęk S; Wojciechowski W
Nutrition; 2024 Apr; 120():112336. PubMed ID: 38237479
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological significances of cribriform pattern in lung adenocarcinoma.
Pyo JS; Lee BH; Min KW; Kim NY
Pathol Res Pract; 2024 Jan; 253():155035. PubMed ID: 38171080
[TBL] [Abstract] [Full Text] [Related]
14. Identification of Candidate mRNA Genes and Their Potential MicroRNA Targets in lung cancer Induced by Smoking Tobacco.
Mishra AK; Mumtaz N; Misra MK
Front Biosci (Schol Ed); 2023 Nov; 15(4):13. PubMed ID: 38163953
[TBL] [Abstract] [Full Text] [Related]
15. Economic evaluation of adjuvant therapy with osimertinib in patients with early-stage non-small cell lung cancer and mutated EGFR.
Vila Pérez A; Alegre-Del Rey EJ; Fénix-Caballero S; Špacírová Z; Rosado Varela P; Olry de Labry Lima A
Support Care Cancer; 2023 Dec; 32(1):67. PubMed ID: 38150163
[TBL] [Abstract] [Full Text] [Related]
16. Single-cell and spatial transcriptomics reveal POSTN
Chen C; Guo Q; Liu Y; Hou Q; Liao M; Guo Y; Zang Y; Wang F; Liu H; Luan X; Liang Y; Guan Z; Li Y; Liu H; Dong X; Zhang X; Liu J; Xu Q
Clin Transl Med; 2023 Dec; 13(12):e1515. PubMed ID: 38115703
[TBL] [Abstract] [Full Text] [Related]
17. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
[TBL] [Abstract] [Full Text] [Related]
18. lung cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines.
Emmerick ICM; Campos MR; Castanheira D; Muzy J; Marques A; Arueira Chaves L; Sobreira da Silva MJ
JAMA Netw Open; 2023 Dec; 6(12):e2346994. PubMed ID: 38079172
[TBL] [Abstract] [Full Text] [Related]
19. Multiplex Immunohistochemistry Staining for Paraffin-embedded lung cancer Tissue.
Yang Y; Huang H; Li L; Yang Y
J Vis Exp; 2023 Nov; (201):. PubMed ID: 38078595
[TBL] [Abstract] [Full Text] [Related]
20. Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
Bauer TM; Santoro A; Lin CC; Garrido-Laguna I; Joerger M; Greil R; Spreafico A; Yau T; Goebeler ME; Hütter-Krönke ML; Perotti A; Juif PE; Lu D; Barys L; Cremasco V; Pelletier M; Evans H; Fabre C; Doi T
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030303
[TBL] [Abstract] [Full Text] [Related]
[Next]
